SDI Reports: amid Swine Flu Fears, New Antiviral Prescriptions Increase over 19 Times in 1 Week

Nearly Twice as High as During 2008 – 2009 Peak Flu Season

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--May 5, 2009 - SDI's Vector One®: National shows that for the week ending May 1, the number of new antiviral prescriptions dispensed at retail pharmacies was 277,196 — over 19 times higher than the prior week.

The number of new antiviral prescriptions last week was nearly double that of new antiviral prescriptions during the peak of the 2008-2009 flu season. According to SDI's Sentinel Laboratory Network, which monitors circulating strains of influenza by tracking influenza type, location, and patient age groups infected, the peak of this most recent flu season was during the week of March 7. The weeks before and after showed new prescriptions ranging from approximately 150,000 to a high of nearly 155,000 during the week ending Feb. 27.

 
VONA® New Antiviral Prescriptions
    Peak Weeks 2008-2009 Flu Season     Two Most Recent Weeks
           
    Week

ending

2/13/09

 

  Week

ending

2/20/09

 

  Week

ending

2/27/09

 

  Week

ending

3/6/09

 

  Week

ending

3/13/09

 

  Week

ending

3/20/09

 

    Week

ending

4/24/09

 

  Week

ending

5/1/09

 

TOTAL MARKET   150,645   136,555   154,673   151,159   128,180   89,684     14,366   277,196
                                   
Relenza   19,298   18,718   23,797   25,591   22,231   14,520     1,349   13,591
Tamiflu   109,230   95,978   107,744   100,840   85,505   59,806     7,422   254,326
All others*   22,117   21,859   23,132   24,728   20,444   15,358     5,595   9,279
*Amantadine, Rimantadine

 

             
               
Vector One®: National (VONA) is SDI's national-level prescription and patient tracking service. VONA provides a comprehensive overview of the national performance of all prescription drugs dispensed by retail pharmacies. Through agreements with data providers, SDI collects a robust sample of retail prescriptions dispensed and projects the activity through methods that stratify by geography, pay type, and class of trade.

Vector One®: National offers the fastest weekly projections available in the industry.

About SDI

Since 1982, SDI has been delivering innovative healthcare data products and analytic services to the pharmaceutical, biotech, healthcare, medical device, financial services, and consumer packaged goods industries. SDI is the leading provider of de-identified patient-level data analytics and offers a broad array of solutions and insights across the continuum of care. These include custom and syndicated patient-level data studies; localized disease and treatment surveillance and projection; market research audits; healthcare profiles; comprehensive managed care offerings; clinical trial optimization; direct-to-patient pharmacy programs; marketing effectiveness; sales targeting and compensation products; data integration, warehousing, and mining; list services; and direct marketing services. Its current roster includes the top 50 pharmaceutical/biotech companies. For more information, visit www.sdihealth.com or call 610.834.0800.

 

Contact: SDI
Tracy Everly, 267-685-4387
teverly@sdihealth.com
or
Buchanan Public Relations
Shannon Bernauer, 610-649.9292
shannon@buchananpr.com

 

Posted: May 2009


View comments

Hide
(web2)